Los Angeles, CANCT05127616Now EnrollingIRB Ready

Urologic Chronic Pelvic Pain Syndrome (UCPPS) Clinical Trial in Los Angeles, CA

Access cutting-edge urologic chronic pelvic pain syndrome (ucpps) treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.

Sponsored by State University of New York at Buffalo

Quick Self-Assessment

See if you qualify for this Los Angeles location

Preparing your pre-screening questions…

Expert Care in Los Angeles

Access urologic chronic pelvic pain syndrome (ucpps) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related urologic chronic pelvic pain syndrome (ucpps) treatment provided free

Apply for This Los Angeles Location

Check if you qualify for this urologic chronic pelvic pain syndrome (ucpps) clinical trial in Los Angeles, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Los Angeles

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Los Angeles site if eligible
  4. 4Begin participation

About This Urologic Chronic Pelvic Pain Syndrome (UCPPS) Study in Los Angeles

The EPPIC (Easing Pelvic Pain Interventions Clinical Research Program) study evaluates an ultra-brief, 4 session cognitive behavioral pain treatment transdiagnostic in design for urologic chronic pain syndrome (UCPPS) with clinical and practical advantages over existing behavioral therapies whose length and focus limits their adoption by clinicians and coverage for mechanistically similar comorbidities. A theoretically informed, practical, empirically grounded approach will systematically unpack CBT's working mechanisms, clarify for whom it works, ease dissemination, appeal to patients, providers, payers, and policy makers in the COVID-19 era favoring low resource intensity treatments, and reduce cost and inefficiencies associated with high intensity therapies whose complexity, length, and scarcity restricts uptake and impact.

Sponsor: State University of New York at Buffalo

Who Can Participate

Inclusion Criteria

Ages 18-70 years (inclusive)
Male or female
All genders, races, ethnic groups
MD-confirmed diagnosis of IC/BPS or CP/CPPS by study urologist or urogynecologist
Pelvic pain including uncomfortable sensations of pressure or discomfort that are not described as outright pain) of at least six months duration
Pelvic pain intensity of at least moderate severity (defined as 3 or greater on a 0-10 Numerical Rating Scale and causes life interference weekly and limit(s) participant's life or work-related activities, general activity level, and/or enjoyment of life) over the past 3 months.
Ability to understand and provide informed consent
Either not taking medications or if taking medications willing to refrain from starting new medications until after the initial 2-week pre-treatment baseline period ends unless medically necessary.
A minimum 6th grade reading level based on the Wide Range Achievement Test (WRAT 4)
Willing to be randomized to either CBT or Support/Education and to follow the protocol to which s/he has been assigned
Willing to be contacted for follow up assessments at week 12 and 3, 6 months after treatment ends
Willing to attend sessions
Able to maintain symptom diaries and complete paper work
Access to telephone and computer or smartphone
Willing and able to provide adequate information for locator purposes

Exclusion Criteria

Urologic-Specific
Presence of a neurological condition (e.g., MS, Parkinson's disease, paraplegia) affecting the bladder
The presence of a symptomatic urethral stricture (males only)
History of cystitis caused by tuberculosis or radiation or chemotherapies
Participant has been diagnosed and treated for a pelvic-related malignancy (colon, bladder, prostate, ovarian, endometrial, uterine, testicular, penile, cervical, vaginal, or rectal cancer) Exclusion Criteria: General
Participant has a medical condition(s) whose nature or severity (unstable, life threatening, etc.) would influence adversely the conduct of the clinical trial, confound interpretation of study results, and/or compromise volunteer safety and engagement with study demands.
Gross cognitive impairment, deafness, blindness, vision problems (severe), hearing problems (severe)
Has a major psychiatric disorder which would impede conduct of the clinical study. These clinical disorders would include but are not limited to major depression with a high risk of suicidal behavior (i.e. intent or plan), current or recent (within the past 3 months) history of alcohol or substance abuse/dependence, a lifetime history of schizophrenia or schizoaffective disorder; or organic mental disorder
Current involvement in psychotherapy directed specifically toward relief of urological symptoms
Schedule does not permit participation in clinic sessions or home practice including plans to move out of the area, lack of reliable transportation, etc.
Characteristics related to inability to complete the study protocol
Unable to read or fluently speak English
Inability to complete screening visits
Inaccessible for interventions and/or follow up evaluations

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Los Angeles?

Yes, this clinical trial (NCT05127616) has an active research site in Los Angeles, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Urologic Chronic Pelvic Pain Syndrome (UCPPS) Treatment Options in Los Angeles, CA

If you're searching for urologic chronic pelvic pain syndrome (ucpps) treatment options in Los Angeles, CA, this clinical trial (NCT05127616) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced urologic chronic pelvic pain syndrome (ucpps) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all urologic chronic pelvic pain syndrome (ucpps) clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Los Angeles, CA

See all pulmonary embolism clinical trials recruiting in Los Angeles — not just this study.

Browse Pulmonary Embolism Trials in Los Angeles →

Browse More Trials by Condition

Pulmonary Embolism TrialsChronic Pain TrialsUlcerative Colitis TrialsInterstitial Cystitis TrialsEndometriosis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Los Angeles?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Los Angeles, CA